JPWO2024242169A5 - - Google Patents
Info
- Publication number
- JPWO2024242169A5 JPWO2024242169A5 JP2025522449A JP2025522449A JPWO2024242169A5 JP WO2024242169 A5 JPWO2024242169 A5 JP WO2024242169A5 JP 2025522449 A JP2025522449 A JP 2025522449A JP 2025522449 A JP2025522449 A JP 2025522449A JP WO2024242169 A5 JPWO2024242169 A5 JP WO2024242169A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- substituted
- ring
- group optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023085585 | 2023-05-24 | ||
| PCT/JP2024/018995 WO2024242169A1 (ja) | 2023-05-24 | 2024-05-23 | 塩誘導性キナーゼ阻害化合物及びそれを含む医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024242169A1 JPWO2024242169A1 (https=) | 2024-11-28 |
| JPWO2024242169A5 true JPWO2024242169A5 (https=) | 2026-02-25 |
Family
ID=93589542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025522449A Pending JPWO2024242169A1 (https=) | 2023-05-24 | 2024-05-23 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20260062387A1 (https=) |
| EP (1) | EP4737443A1 (https=) |
| JP (1) | JPWO2024242169A1 (https=) |
| KR (1) | KR20260015855A (https=) |
| CN (1) | CN121358713A (https=) |
| AR (1) | AR132761A1 (https=) |
| AU (1) | AU2024276075A1 (https=) |
| IL (1) | IL324835A (https=) |
| MX (1) | MX2025013981A (https=) |
| TW (1) | TW202509021A (https=) |
| WO (1) | WO2024242169A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240124450A1 (en) * | 2022-09-21 | 2024-04-18 | Pfizer Inc. | Novel SIK Inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7488745B2 (en) | 2004-07-16 | 2009-02-10 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
| WO2013144191A1 (de) | 2012-03-29 | 2013-10-03 | Bayer Intellectual Property Gmbh | Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen |
| US9688680B2 (en) | 2014-08-04 | 2017-06-27 | Blueprint Medicines Corporation | Compositions useful for treating disorders related to kit |
| EP3717471B1 (en) * | 2017-12-02 | 2022-01-05 | Galapagos NV | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| MA52873A (fr) * | 2018-06-15 | 2021-04-21 | Galapagos Nv | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies |
| CA3112326A1 (en) | 2018-09-12 | 2020-03-19 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| GB201907616D0 (en) * | 2019-05-29 | 2019-07-10 | Galapagos Nv | Novel compounds and pharmaceutical compositons thereof for the treatment of diseases |
| GB201907558D0 (en) | 2019-05-29 | 2019-07-10 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| US20240010652A1 (en) | 2020-10-14 | 2024-01-11 | Blueprint Medicines Corporation | Compositions and methods for treating kit- and pdgfra-mediated diseases |
| CN115448881A (zh) | 2021-06-09 | 2022-12-09 | 江苏恒瑞医药股份有限公司 | 杂芳基类化合物、其制备方法及其在医药上的应用 |
| JP7290703B1 (ja) | 2021-11-30 | 2023-06-13 | ハシダ技研工業株式会社 | 樹脂成形品の製造方法 |
-
2024
- 2024-05-23 EP EP24811175.9A patent/EP4737443A1/en active Pending
- 2024-05-23 AR ARP240101301A patent/AR132761A1/es unknown
- 2024-05-23 AU AU2024276075A patent/AU2024276075A1/en active Pending
- 2024-05-23 WO PCT/JP2024/018995 patent/WO2024242169A1/ja not_active Ceased
- 2024-05-23 JP JP2025522449A patent/JPWO2024242169A1/ja active Pending
- 2024-05-23 KR KR1020257041596A patent/KR20260015855A/ko active Pending
- 2024-05-23 CN CN202480026705.2A patent/CN121358713A/zh active Pending
- 2024-05-23 TW TW113119171A patent/TW202509021A/zh unknown
- 2024-05-23 IL IL324835A patent/IL324835A/en unknown
-
2025
- 2025-11-10 US US19/383,969 patent/US20260062387A1/en active Pending
- 2025-11-21 MX MX2025013981A patent/MX2025013981A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910019615A (ko) | 위산분비 억제 방법 | |
| RU98112606A (ru) | Новые производные пиразола, способ их получения и содержащих их фармацевтические композиции | |
| RU2342383C2 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗОЛ-4-ИЛЭТИНИЛПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНКСИОЛИТИКА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ НАРУШЕНИЙ, ОПОСРЕДУЕМЫХ РЕЦЕПТОРОМ mGLuR5 | |
| AR119028A1 (es) | Derivados de imidazoles y pirazoles condensados, composiciones farmacéuticas de los mismos y su uso en el tratamiento de enfermedades inflamatorias, autoinflamatorias, autoinmunes, proliferativas y angiogénesis | |
| JP2005535586A5 (https=) | ||
| JPWO2024242169A5 (https=) | ||
| JP2004506736A5 (https=) | ||
| EP1915994B1 (en) | Cyclic amine derivatives in combination with ppar regulators | |
| JP2023509422A5 (https=) | ||
| RU2010111550A (ru) | 2,3-замещенные индольные производные для лечения вирусных инфекций | |
| JP2023521351A5 (https=) | ||
| JP2013538235A5 (https=) | ||
| JP2007519695A5 (https=) | ||
| JP2005537248A5 (https=) | ||
| CA2503445A1 (en) | Methylene urea derivatives as raf-kinase inhibitors | |
| RU2008147095A (ru) | Макролидные производные | |
| JP2022505645A5 (https=) | ||
| JP2005511545A5 (https=) | ||
| JP2019507114A5 (https=) | ||
| AR121299A1 (es) | Inhibidores heterocíclicos de pad4 | |
| JP2005536519A5 (https=) | ||
| JP2022521955A5 (https=) | ||
| JP2023531495A5 (https=) | ||
| JP2024518447A5 (https=) | ||
| JP2005526773A5 (https=) |